|
IT1154655B
(it)
|
1980-05-22 |
1987-01-21 |
Alfa Farmaceutici Spa |
Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
|
|
CA1215976A
(en)
|
1984-05-15 |
1986-12-30 |
Vincenzo Cannata |
New process for the synthesis of imidazo rifamycins
|
|
IT1199374B
(it)
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1199413B
(it)
|
1984-09-26 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
US5356625A
(en)
|
1986-08-28 |
1994-10-18 |
Enzacor Properties Limited |
Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
IT1253711B
(it)
|
1991-12-17 |
1995-08-23 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
|
|
IT1264494B1
(it)
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US5840332A
(en)
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
|
EP0935417B1
(en)
|
1996-10-16 |
2009-05-06 |
Napo Pharmaceuticals, Inc. |
Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
|
|
IT1290679B1
(it)
|
1997-02-14 |
1998-12-10 |
Alfa Wassermann Spa |
Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
|
|
US6770623B1
(en)
|
1997-12-09 |
2004-08-03 |
Eli Lilly And Company |
Stabilized teriparatide solutions
|
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
US20030157174A1
(en)
|
2000-03-23 |
2003-08-21 |
Takayuki Tsukuda |
Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component
|
|
DE10045547A1
(de)
|
2000-09-14 |
2002-04-04 |
Infineon Technologies Ag |
Verfahren zur systemunabhängigen digitalen Erzeugung von Mobilkommunikations-Sendesignalen verschiedener Mobilfunkstandards
|
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
US20080262024A1
(en)
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
ITMI20032144A1
(it)
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US7923553B2
(en)
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
US7902206B2
(en)
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US7906542B2
(en)
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
US20050196418A1
(en)
|
2004-03-04 |
2005-09-08 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
SE528938C2
(sv)
|
2005-02-08 |
2007-03-20 |
Ortic Ab |
Hydroformningsenhet
|
|
US8003118B2
(en)
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210483A1
(en)
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
US20060210492A1
(en)
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
PT1698630E
(pt)
|
2005-03-03 |
2014-09-15 |
Alfa Wassermann Spa |
Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
KR101667534B1
(ko)
|
2006-09-22 |
2016-10-19 |
씨아이피엘에이 엘티디. |
리팍시민
|
|
ITMI20071241A1
(it)
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
EP2011486B2
(en)
|
2007-07-06 |
2015-08-12 |
Lupin Ltd. |
Pharmaceutical compositions of rifaximin
|
|
JP5755878B2
(ja)
|
2007-07-06 |
2015-07-29 |
ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ |
リファキシミンの薬剤組成物
|
|
WO2009008006A2
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
|
US7709634B2
(en)
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
WO2009047801A1
(en)
|
2007-10-10 |
2009-04-16 |
Lupin Limited |
Therapeutic combinations and compositions for the treatment of gastrointestinal disorders
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
UA113275C2
(xx)
|
2008-02-25 |
2017-01-10 |
|
ζ-ФОРМА РИФАКСИМІНУ І ЇЇ ЗАСТОСУВАННЯ
|
|
PT2252148T
(pt)
|
2008-02-26 |
2020-01-23 |
Salix Pharmaceuticals Ltd |
Métodos de tratamento da síndrome do intestino irritável
|
|
US20110035232A1
(en)
|
2008-10-02 |
2011-02-10 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
US7928115B2
(en)
|
2008-10-02 |
2011-04-19 |
Salix Pharmaceuticals, Ltd. |
Methods of treating travelers diarrhea and hepatic encephalopathy
|
|
HUE048293T2
(hu)
|
2008-10-02 |
2020-07-28 |
Salix Pharmaceuticals Ltd |
Eljárások hepatikus enkefalopátia kezelésére
|
|
WO2010044093A1
(en)
|
2008-10-16 |
2010-04-22 |
Strides Arcolab Limited |
Formulations containing rifaximin
|
|
ES2718614T3
(es)
|
2008-12-10 |
2019-07-03 |
Cipla Ltd |
Complejos de rifaximina
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
PT2493471T
(pt)
|
2009-10-26 |
2020-01-09 |
Borody Thomas J |
Nova terapia de combinação entérica
|
|
MY177151A
(en)
|
2009-10-27 |
2020-09-08 |
Lupin Ltd |
Solid dispersion of rifaximin
|
|
WO2011061748A1
(en)
|
2009-11-19 |
2011-05-26 |
Strides Arcolab Limited |
Rifaximin premix
|
|
US20130202654A1
(en)
|
2009-11-23 |
2013-08-08 |
Cipla Limited |
Topical Foam Composition
|
|
RU2012126084A
(ru)
|
2009-11-23 |
2013-12-27 |
Сипла Лимитед |
Пенная композиция для местного применения
|
|
WO2011080691A1
(en)
|
2009-12-28 |
2011-07-07 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
CN101773465B
(zh)
|
2010-01-19 |
2012-11-07 |
南京泛太化工医药研究所 |
以氨基酸为稳定剂的聚合物胶束载药系统
|
|
AU2011225810B2
(en)
|
2010-03-10 |
2014-11-06 |
Lupin Limited |
Rifaximin ready-to-use suspension
|
|
EA022490B1
(ru)
|
2010-06-03 |
2016-01-29 |
Саликс Фармасьютикалс, Лтд. |
Новые формы рифаксимина и их применение
|
|
CA2802874A1
(en)
|
2010-06-16 |
2011-12-22 |
Apotex Pharmachem Inc. |
Polymorphic forms of rifaximin
|
|
ES2801678T3
(es)
|
2010-07-12 |
2021-01-12 |
Salix Pharmaceuticals Inc |
Formulaciones de rifaximina y sus usos
|
|
MX2013002802A
(es)
|
2010-09-13 |
2013-06-03 |
Cipla Ltd |
Composicion farmaceutica.
|
|
IT1403847B1
(it)
|
2010-09-22 |
2013-11-08 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina e loro uso.
|
|
WO2012060675A1
(es)
|
2010-11-05 |
2012-05-10 |
Interquim, S.A. De C.V. |
Proceso para la preparación de rifaximina amorfa
|
|
WO2012076832A1
(en)
|
2010-12-09 |
2012-06-14 |
Cipla Limited |
Suppositories comprising rifaximin
|
|
SG192122A1
(en)
*
|
2011-02-11 |
2013-08-30 |
Salix Pharmaceuticals Ltd |
Forms of rifaximin and uses thereof
|
|
WO2012150561A1
(en)
|
2011-05-02 |
2012-11-08 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
WO2012155981A1
(en)
|
2011-05-19 |
2012-11-22 |
Friulchem Spa |
New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
JP2013184902A
(ja)
|
2012-03-06 |
2013-09-19 |
Aska Pharmaceutical Co Ltd |
リファキシミン含有結晶
|
|
CA2876737A1
(en)
|
2012-06-13 |
2013-12-19 |
Apotex Pharmachem Inc. |
Polymorphic forms of rifaximin
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
US9849090B2
(en)
|
2012-12-12 |
2017-12-26 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of rifaximin
|
|
EP2983647B1
(en)
|
2013-04-12 |
2020-09-09 |
Alfasigma S.p.A. |
Nsaid administration and related compositions, methods and systems
|
|
EP2997034A4
(en)
|
2013-05-17 |
2016-12-28 |
Salix Pharmaceuticals Inc |
METHODS OF USING RIFAXIMINE IN POSITRON EMISSION TOMOGRAPHY SCANNING (PET)
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
ITMI20131307A1
(it)
|
2013-08-02 |
2015-02-02 |
A M S A Anonima Materie Sint & Affini S P A |
Processo per la preparazione di refaximina k
|
|
ES2621557T3
(es)
|
2014-03-31 |
2017-07-04 |
Euticals S.P.A. |
Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
|
|
EP3134415A4
(en)
|
2014-04-19 |
2017-10-25 |
Granules India Limited |
An improved process for the preparation of rifamycin derivatives
|
|
NZ723571A
(en)
|
2014-05-12 |
2020-02-28 |
Alfasigma Spa |
New solvated crystal form of rifaximin, production, compositions and uses thereof
|
|
WO2016063289A2
(en)
|
2014-10-22 |
2016-04-28 |
Strides Arcolab Limited |
Pharmaceutical tablet compositions comprising rifaximin
|
|
WO2017021975A1
(en)
|
2015-08-06 |
2017-02-09 |
Msn Laboratories Private Limited |
Process for the preparation of crystalline forms of rifaximin
|
|
WO2017162725A1
(en)
|
2016-03-24 |
2017-09-28 |
Sandoz Ag |
Pharmaceutical composition containing rifaximin alpha & delta
|
|
TR201909029T4
(tr)
|
2016-03-24 |
2019-07-22 |
Sandoz Ag |
Rifaksimin alfa içeren saklanmaya yönelik kararlı bileşimler.
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
WO2018158646A1
(en)
|
2017-03-02 |
2018-09-07 |
Granules India Limited |
Rifaximin crystalline form
|
|
WO2018178777A1
(en)
|
2017-03-31 |
2018-10-04 |
Granules India Limited |
Process for the preparation of rifaximin crystalline form
|
|
PL3416627T3
(pl)
|
2017-04-26 |
2020-06-01 |
Sandoz Ag |
Doustna postać dawkowania zawierająca rifaksyminę w postaci beta
|